Skip to Content

JSP 545 (Digoxin 250 mcg (0.25 mg))

Pill with imprint JSP 545 is White, Round and has been identified as Digoxin 250 mcg (0.25 mg). It is supplied by Lannett Company, Inc..

Digoxin is used in the treatment of atrial fibrillation; heart failure and belongs to the drug classes group V antiarrhythmics, inotropic agents. Risk cannot be ruled out during pregnancy. Digoxin 250 mcg (0.25 mg) is not a controlled substance under the Controlled Substances Act (CSA).

Images for JSP 545

Digoxin 250 mcg (0.25 mg) JSP 545
Digoxin 250 mcg (0.25 mg) JSP 545
Digoxin 250 mcg (0.25 mg) JSP 545  Front
Digoxin 250 mcg (0.25 mg) JSP 545  Back
Digoxin 250 mcg (0.25 mg) JSP 545

Digoxin

Imprint
JSP 545
Strength
250 mcg (0.25 mg)
Color
White
Size
7.00 mm
Shape
Round
Availability
Prescription only
Drug Class
Group V antiarrhythmics, Inotropic agents
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Lannett Company, Inc.
National Drug Code (NDC)
00527-1325
Inactive Ingredients
silicon dioxide, croscarmellose sodium, lactose anhydrous, magnesium stearate, microcrystalline cellulose, stearic acid

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.